Plantar Load Analysis of Neuropathic and Neuroischaemic Diabetes-Related Foot Ulceration
Key facts
- Who runs it
- The Leeds Teaching Hospitals NHS Trust
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 16 people enrolled
- Started
- 25 Oct 2025
- Ended
- 1 Apr 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Pedar™ In-Shoe Plantar Pressure Measurement System
- STAMPS 3D Digital Image Correlation System
- Weight-Bearing Ultrasound of the Plantar Fat Pad
- Record updated
- 28 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age > 18 years
- Confirmed diabetes mellitus (type 1 or 2)
- Recently healed plantar DFU (forefoot, <3months)
- Able to walk 10m unaided
- Able to provide written consent
Who cannot take part
- Previous ipsilateral minor amputation or contralateral major lower limb amputation
- Active ulceration or infection
- Hindfoot or non-plantar ulcer location
- Non-diabetic aetiology
- Need for a walking aid
- Inability to understand English instructions
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This single-centre observational case-control study investigates how peripheral arterial disease influences plantar load in people with diabetes who have recently healed a plantar foot ulcer. Using in-shoe pressure mapping (Pedar™) and 3D digital image correlation of a plasticine deformable insole (STAMPS system), we will quantify vertical pressure and strain magnitude. Weight-bearing ultrasound will assess plantar fat-pad thickness as a potential corollary for forefoot peak pressure and shear. All procedures are non-invasive and completed in a single ~90-minute visit at Leeds Teaching Hospitals NHS Trust.
The 2 groups in the trial
- Neuropathic Diabetes-related Foot Ulcer (DFU) Cohort
Participants with diabetes and a recently healed plantar forefoot (\<3 months) ulcer caused by neuropathic ulceration in the presence of preserved perfusion. Sensory neuropathy is confirmed by insensitivity to the 10 g monofilament (Ipswich Touch Test). Participants have at least one palpable pedal pulse and at least one multiphasic pedal Doppler signal, with opening toe pressure ≥ 60 mmHg. No history of lower-limb revascularisation.
Treatment: Pedar™ In-Shoe Plantar Pressure Measurement System, STAMPS 3D Digital Image Correlation System, and Weight-Bearing Ultrasound of the Plantar Fat Pad
- Neuroischaemic Diabetes-related Foot Ulcer (DFU) Cohort
Participants with diabetes and a recently healed plantar forefoot (\<3 months) of neuroischaemic aetiology, showing both sensory neuropathy and peripheral arterial disease. PAD is defined as a prior revascularisation procedure or by the absence of pedal pulses and monophasic or absent Doppler signal with an opening toe pressure ≤ 50 mmHg.
Treatment: Pedar™ In-Shoe Plantar Pressure Measurement System, STAMPS 3D Digital Image Correlation System, and Weight-Bearing Ultrasound of the Plantar Fat Pad
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Plantar Load Analysis of Neuropathic and Neuroischaemic Diabetes-Related Foot Ulceration (PLANE-DFU): Investigating Plantar Pressure and Shear in Neuropathic Versus Neuroischaemic Diabetes-Related Foot Ulceration
- Record updated
- 28 October 2026